BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30833417)

  • 1. Base excision repair deficiency signatures implicate germline and somatic
    Thibodeau ML; Zhao EY; Reisle C; Ch'ng C; Wong HL; Shen Y; Jones MR; Lim HJ; Young S; Cremin C; Pleasance E; Zhang W; Holt R; Eirew P; Karasinska J; Kalloger SE; Taylor G; Majounie E; Bonakdar M; Zong Z; Bleile D; Chiu R; Birol I; Gelmon K; Lohrisch C; Mungall KL; Mungall AJ; Moore R; Ma YP; Fok A; Yip S; Karsan A; Huntsman D; Schaeffer DF; Laskin J; Marra MA; Renouf DJ; Jones SJM; Schrader KA
    Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30833417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-Cancer Interrogation of
    Paller CJ; Tukachinsky H; Maertens A; Decker B; Sampson JR; Cheadle JP; Antonarakis ES
    JCO Precis Oncol; 2024 Feb; 8():e2300251. PubMed ID: 38394468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoallelic deleterious MUTYH germline variants as a driver for tumorigenesis.
    Barreiro RAS; Sabbaga J; Rossi BM; Achatz MIW; Bettoni F; Camargo AA; Asprino PF; A F Galante P
    J Pathol; 2022 Feb; 256(2):214-222. PubMed ID: 34816434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers.
    Georgeson P; Pope BJ; Rosty C; Clendenning M; Mahmood K; Joo JE; Walker R; Hutchinson RA; Preston S; Como J; Joseland S; Win AK; Macrae FA; Hopper JL; Mouradov D; Gibbs P; Sieber OM; O'Sullivan DE; Brenner DR; Gallinger S; Jenkins MA; Winship IM; Buchanan DD
    Gut; 2021 Nov; 70(11):2138-2149. PubMed ID: 33414168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic c.34G>T KRAS mutation: a new prescreening test for MUTYH-associated polyposis?
    Aimé A; Coulet F; Lefevre JH; Colas C; Cervera P; Flejou JF; Lascols O; Soubrier F; Parc Y
    Cancer Genet; 2015; 208(7-8):390-5. PubMed ID: 26056087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of germline MUTYH mutations among Lynch-like syndrome patients.
    Castillejo A; Vargas G; Castillejo MI; Navarro M; Barberá VM; González S; Hernández-Illán E; Brunet J; Ramón y Cajal T; Balmaña J; Oltra S; Iglesias S; Velasco A; Solanes A; Campos O; Sánchez Heras AB; Gallego J; Carrasco E; González Juan D; Segura A; Chirivella I; Juan MJ; Tena I; Lázaro C; Blanco I; Pineda M; Capellá G; Soto JL
    Eur J Cancer; 2014 Sep; 50(13):2241-50. PubMed ID: 24953332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using tumor mutational signatures.
    Georgeson P; Harrison TA; Pope BJ; Zaidi SH; Qu C; Steinfelder RS; Lin Y; Joo JE; Mahmood K; Clendenning M; Walker R; Amitay EL; Berndt SI; Brenner H; Campbell PT; Cao Y; Chan AT; Chang-Claude J; Doheny KF; Drew DA; Figueiredo JC; French AJ; Gallinger S; Giannakis M; Giles GG; Gsur A; Gunter MJ; Hoffmeister M; Hsu L; Huang WY; Limburg P; Manson JE; Moreno V; Nassir R; Nowak JA; Obón-Santacana M; Ogino S; Phipps AI; Potter JD; Schoen RE; Sun W; Toland AE; Trinh QM; Ugai T; Macrae FA; Rosty C; Hudson TJ; Jenkins MA; Thibodeau SN; Winship IM; Peters U; Buchanan DD
    Nat Commun; 2022 Jun; 13(1):3254. PubMed ID: 35668106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas.
    Pilati C; Shinde J; Alexandrov LB; Assié G; André T; Hélias-Rodzewicz Z; Ducoudray R; Le Corre D; Zucman-Rossi J; Emile JF; Bertherat J; Letouzé E; Laurent-Puig P
    J Pathol; 2017 May; 242(1):10-15. PubMed ID: 28127763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUTYH exon 7 and 13 mutations associated with colorectal cancer (MAP syndrome) are not commonly associated with sporadic pancreatic cancer.
    Smith LM; Sharif S; Brand R; Fink E; Lamb J; Whitcomb DC
    Pancreatology; 2009; 9(6):793-6. PubMed ID: 20110747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue.
    van Puijenbroek M; Nielsen M; Tops CM; Halfwerk H; Vasen HF; Weiss MM; van Wezel T; Hes FJ; Morreau H
    Clin Cancer Res; 2008 Jan; 14(1):139-42. PubMed ID: 18172263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial cancer may be part of the MUTYH-associated polyposis cancer spectrum.
    Villy MC; Masliah-Planchon J; Buecher B; Beaulaton C; Vincent-Salomon A; Stoppa-Lyonnet D; Colas C
    Eur J Med Genet; 2022 Jan; 65(1):104385. PubMed ID: 34775073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the base excision repair gene MUTYH in sporadic colorectal cancer.
    Kuno T; Matsubara N; Tsuda S; Kobayashi M; Hamanaka M; Yamagishi D; Tsukamoto K; Yamano T; Noda M; Ikeuchi H; Kim S; Tamura K; Tomita N
    Oncol Rep; 2012 Aug; 28(2):473-80. PubMed ID: 22641385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial cancer and somatic G>T KRAS transversion in patients with constitutional MUTYH biallelic mutations.
    Tricarico R; Bet P; Ciambotti B; Di Gregorio C; Gatteschi B; Gismondi V; Toschi B; Tonelli F; Varesco L; Genuardi M
    Cancer Lett; 2009 Feb; 274(2):266-70. PubMed ID: 18980800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First report of medulloblastoma in a patient with MUTYH-associated polyposis.
    Villy MC; Warcoin M; Filser M; Buecher B; Golmard L; Suybeng V; Schwartz M; Bieche I; Vacher S; Laurence V; Bourdeaut F; Bernier M; Gutman T; Stoppa-Lyonnet D; Masliah-Planchon J; Colas C
    Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12929. PubMed ID: 37524406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.
    Lejeune S; Guillemot F; Triboulet JP; Cattan S; Mouton C; ; Porchet N; Manouvrier S; Buisine MP
    Hum Mutat; 2006 Oct; 27(10):1064. PubMed ID: 16941501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited MUTYH mutations cause elevated somatic mutation rates and distinctive mutational signatures in normal human cells.
    Robinson PS; Thomas LE; Abascal F; Jung H; Harvey LMR; West HD; Olafsson S; Lee BCH; Coorens THH; Lee-Six H; Butlin L; Lander N; Truscott R; Sanders MA; Lensing SV; Buczacki SJA; Ten Hoopen R; Coleman N; Brunton-Sim R; Rushbrook S; Saeb-Parsy K; Lalloo F; Campbell PJ; Martincorena I; Sampson JR; Stratton MR
    Nat Commun; 2022 Jul; 13(1):3949. PubMed ID: 35803914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative Damage in Sporadic Colorectal Cancer: Molecular Mapping of Base Excision Repair Glycosylases MUTYH and hOGG1 in Colorectal Cancer Patients.
    Kavec MJ; Urbanova M; Makovicky P; Opattová A; Tomasova K; Kroupa M; Kostovcikova K; Siskova A; Navvabi N; Schneiderova M; Vymetalkova V; Vodickova L; Vodicka P
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association between MUTYH and MSH6 germline mutations in 64 HNPCC patients.
    Steinke V; Rahner N; Morak M; Keller G; Schackert HK; Görgens H; Schmiegel W; Royer-Pokora B; Dietmaier W; Kloor M; Engel C; Propping P; Aretz S;
    Eur J Hum Genet; 2008 May; 16(5):587-92. PubMed ID: 18301448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUTYH-associated tumor syndrome: The other face of MAP.
    Magrin L; Fanale D; Brando C; Corsini LR; Randazzo U; Di Piazza M; Gurrera V; Pedone E; Bazan Russo TD; Vieni S; Pantuso G; Russo A; Bazan V
    Oncogene; 2022 Apr; 41(18):2531-2539. PubMed ID: 35422474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUTYH hotspot mutations in unselected colonoscopy patients.
    Casper M; Plotz G; Juengling B; Zeuzem S; Lammert F; Raedle J
    Colorectal Dis; 2012 May; 14(5):e238-44. PubMed ID: 22469480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.